{"id":"W1979887570","doi":"10.2310/7750.2008.08002","title":"Use of Biologic Therapeutics in Difficult-to-Treat Psoriasis","year":2009,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Etanercept; Infliximab; Formulary; Randomized controlled trial; Intensive care medicine; Dermatology; Clinical trial; Plaque psoriasis; Surgery; Pharmacology; Disease; Immunology; Internal medicine; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004945535,0.0002634055,0.0008031368,0.001564739,0.0003478054,0.001118805,0.0004028789,0.0009839287,0.003176301],"category_scores_gemma":[0.008804128,0.00008182384,0.0005592433,0.0009754089,0.001035662,0.0009605793,0.0007858239,0.0009048566,0.000472301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006422587,"about_ca_system_score_gemma":0.0009200966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003075337,"about_ca_topic_score_gemma":0.0005441775,"domain_scores_codex":[0.994558,0.002922411,0.0007616719,0.0002177375,0.001376771,0.0001635045],"domain_scores_gemma":[0.9918582,0.004655879,0.002401977,0.0002988506,0.0005237245,0.0002613372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002218575,0.0008160439,0.0287879,0.01988529,0.0005851435,0.002080906,0.001139055,0.0004742997,0.006447732,0.008166811,0.006669321,0.9227288],"study_design_scores_gemma":[0.00315986,0.01830506,0.1439843,0.04703056,0.003870561,0.08157939,0.004367469,0.001621981,0.02483091,0.02652311,0.6445675,0.0001592908],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.08207595,0.8852393,0.002412907,0.007554284,0.0003563178,0.0001671413,0.0001167402,0.00004112087,0.02203616],"genre_scores_gemma":[0.6571109,0.3316289,0.005627174,0.003466173,0.0008362588,0.0001507812,0.000134119,0.00001906733,0.001026639],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004945535,"threshold_uncertainty_score":0.02615476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05836213500273379,"score_gpt":0.2718810860822946,"score_spread":0.2135189510795608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}